Target intelligence / Profile preview

5S ribosomal RNA pseudogene 280 (RNA5SP280)

Target
RNA5SP280
Molecular classification
Processed pseudogene, RNA pseudogene, Non-coding RNA, rRNA pseudogene
01

Overview

5S ribosomal RNA pseudogene 280 (RNA5SP280) is a processed pseudogene derived from the 5S ribosomal RNA gene family. Unlike active 5S rRNA genes, pseudogenes such as RNA5SP280 are nonfunctional DNA sequences that have lost the ability to be transcribed into functional RNA or to contribute to ribosome biogenesis. While canonical 5S rRNA is an integral component of the large ribosomal subunit and essential for ribosome function[1][3], pseudogenes like RNA5SP280 generally do not encode functional products, though some pseudogenes in general may have regulatory effects on gene expression at the RNA level[2][6]. There is no evidence to suggest this specific pseudogene acts as a therapeutic target or is directly associated with disease mechanisms. Its main relevance is as a genomic element reflecting the evolutionary history of the ribosomal RNA gene family.\nRNA5SP280 is not a functional receptor, enzyme, transporter, or traditional drug target. It is a pseudogene and is not considered a therapeutic target[4]. Its primary relevance is in genomics and molecular biology, not clinical targeting or pharmacology. If a functional 5S rRNA gene or its mature RNA species is intended, nomenclature should reflect "5S ribosomal RNA" or the equivalent gene (e.g., RN5S1). The designation here is clearly for a pseudogene and appears to be an accurate representation as such. However, it is not a therapeutic target, and use as such would be incorrect[3][4].

Other names
RN5S280RNA, 5S ribosomal 280RNA5SP280
02

Mechanism of action

None known

03

Biological functions

Pseudogenes may participate in regulation of gene expression at the RNA level, for example, acting as antisense transcripts or miRNA decoys in some contexts[2][6].No direct functional role in ribosomal activity or canonical translation.
04

Disease associations

Certain pseudogenes have been associated with cancer, acting as regulatory RNAs or biomarkers, but specific evidence for RNA5SP280 is lacking[6].Other
05

Biomarkers

Not established for patient selection or efficacy monitoring

Beyond the preview

Go deeper on 5S ribosomal RNA pseudogene 280 (RNA5SP280).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5S ribosomal RNA pseudogene 280 (RNA5SP280).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call